Navigation Links
Guanilib in Medical Technology

Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis

Announces Positive Data in Animal Models of Ulcerative Colitis NEW YORK, April 05, 2007 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. , a developer of new drug treatments in the fight against cancer and other major health threats, announced today additional data confirming efficacy of G...

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

... significantly reduced cardiotoxicity, or damage to the heart, compared to currently available drug alternatives. Callisto also has a proprietary drug guanilib in preclinical development for gastro- intestinal disorders. Callisto has exclusive worldwide licenses from Genzyme Inc. and M.D. Anderson Cancer Cent...

Callisto Reports on Second-Quarter 2007 Milestones

...s currently suffering from these maladies." About guanilib guanilib (also called SP-304) is a potent analog (synthetic...llisto scientists, and is proprietary to Callisto. guanilib has been demonstrated to be superior to uroguanyli...

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

... significantly reduced cardiotoxicity, or damage to the heart, compared to currently available drug alternatives. Callisto also has a proprietary drug guanilib in preclinical development for gastro- intestinal disorders. Callisto has exclusive worldwide licenses from Genzyme Inc. and M.D. Anderson Cancer Cent...
Other Tags
(Date:6/1/2015)... IPSWICH, Mass. (PRWEB) June 01, 2015 ... decision support solutions, today introduced DynaMed Plus™ , ... and other medical professionals. It provides clinicians with the ... determine optimal patient care paths. , DynaMed Plus ... the market and includes the most frequently updated evidence-based ...
(Date:6/1/2015)... PA (PRWEB) June 01, 2015 Note: ... new development in breast cancer prevention. , A phase ... suggests that postmenopausal women with ductal carcinoma in situ ... treatment and prevention. , The study (NSABP B-35/NRG Oncology) ... who completed the standard five-year treatment with tamoxifen to ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 There’s never a ... when it comes to non-emergency, minor illnesses. , As of ... 24/7 online access to medical care via the Internet. Patients ... smartphone, tablet or computer. , “Everyone is busy. We know ... a challenge, so we want to make it easier,” said ...
(Date:6/1/2015)... Texas (PRWEB) June 01, 2015 Carrick ... brain health landscape on a global level. This ... realms, allowing Carrick Brain Centers to broaden their scope ... healing. , Broadened horizons are accompanied by a restructuring ... 1, 2015, Carrick Brain Centers will separate itself from ...
(Date:6/1/2015)... 01, 2015 A University of ... inhibits signaling proteins that activate protein degradation, which ... exercise. 1 , The study published April ... male Spraque-Dawley rats 2-3 months of age who ... were given either whey protein (.4g/kg), low-dose Sustamine ...
Breaking Medicine News(10 mins):Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Carrick Brain Centers announces separation from Dr. Frederick Carrick to reflect the broader scope of impact and growth as an organization. 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 2Health News:Study Shows Taking Sustamine® L-Alanyl-L-Glutamine May Reduce Muscle Protein Breakdown After Resistance Exercise 3
(Date:5/11/2015)... May 11, 2015  Through a well-rounded UAS delegation representing ... had a strong showing at AUVSI,s Unmanned 2015 conference last ... Ohio,s UAS industry met with over ... all points along the UAS ecosystem. "Our ... Vice President for Aerospace Rich Knoll . "If you ...
(Date:5/6/2015)... TEL AVIV, Israel , May 6, 2015 /PRNewswire/ ... the world,s most established helmet producer, announced today that ... LifeBEAM Smart Helmet, the world,s first bio-sensing cycling helmet ... will be released in two new colors in order ... demand for the product. In addition, LifeBEAM and Lazer ...
(Date:4/21/2015)... 21, 2015 High crime ... are boosting access control systems market in ... a recently published report by TechSci Research " Saudi ... access control systems market in Saudi Arabia ... 2020.The access control systems market in the Kingdom is ...
Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3
Other Contents